文献速递睡眠呼吸障碍小儿耳鼻咽喉

儿童腺样体扁桃体切除术试验的二次分析:一项叙述性综述

Secondary Analyses of the Childhood Adenotonsillectomy Trial: A Narrative Review.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2022-01-01

本文综述儿童腺样体扁桃体切除术试验(CHAT)数据集的二次分析,CHAT是首个检验早期腺样体扁桃体切除术(eAT)对比观察等待治疗儿童非重度阻塞性睡眠呼吸暂停(OSA)疗效的随机临床试验。多数二次分析提示eAT组在症状负担、嗜睡、家长报告的行为和生活质量方面改善最大,认知、心血管生理和代谢指标变化有限,症状不能预测OSA严重程度。

要点

  • 多数二次分析提示eAT组在症状负担、嗜睡、家长报告行为和生活质量方面改善最大。
  • 认知、心血管生理和代谢指标的变化有限且具有选择性。
  • 多数治疗结局与多导睡眠图参数关联弱,症状不能预测OSA严重程度。

核心结论

  • CHAT为未来儿童OSA相关研究的设计、实施和数据集后续再利用提供了范本,其发现推进了对儿童非重度OSA病理生理和管理的理解。
  • 未来研究方向包括这些发现是否可推广至更年幼儿童以及原发性打鼾和重度OSA儿童。

研究设计与样本

  • 叙述性综述,聚焦于CHAT数据集相关的二次分析,按结局指标分组。
  • CHAT是首个检验腺样体扁桃体切除术疗效的随机临床试验,比较早期腺样体扁桃体切除术(eAT)与观察等待加支持治疗对儿童非重度OSA的管理。
  • CHAT数据通过国家睡眠研究资源库公开,使研究者能够探讨与儿童OSA照护相关的额外临床问题。

主要发现

  • 多数二次分析结果提示,接受eAT的儿童在症状负担、嗜睡、家长报告的行为和生活质量方面改善最大。
  • 认知、心血管生理和代谢指标等其他领域的变化有限且具有选择性。
  • 多数治疗结局与多导睡眠图参数之间的关联弱。
  • 症状不能很好地预测OSA严重程度。

局限性

  • CHAT排除了较年幼的学龄前儿童和原发性打鼾儿童,限制了研究结果的推广性。
  • 由于照护者未设盲,部分家长报告的结局可能被夸大。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Adenotonsillectomy, performed for approximately 500 000 children annually in the US alone, is the first line of treatment of pediatric obstructive sleep apnea (OSA). The Childhood Adenotonsillectomy Trial (CHAT), the first randomized clinical trial to test the efficacy of adenotonsillectomy, compared the management of pediatric nonsevere OSA by early adenotonsillectomy (eAT) vs watchful waiting with supportive care. Since the publication of the primary article in 2013, the CHAT study data set were made available via the National Sleep Research Resource, which allowed researchers to address a range of additional clinical questions relevant to the care of children with OSA. This review focuses on secondary analyses associated with the CHAT data set as grouped by the outcome of interest. OBSERVATIONS: The results of most secondary analyses suggest that children who underwent eAT experienced the greatest improvements in symptom burden, sleepiness, parent-reported behavior, and quality of life. Changes in other domains, such as cognition, cardiovascular physiology, and metabolic indicators, were modest and selective. The associations between most treatment outcomes and polysomnographic parameters were weak. Symptoms were poor predictors of OSA severity. The results from these secondary analyses benefitted from the rigor of multicenter design and centralized polysomnography interpretation in CHAT. However, the exclusion of younger preschool-aged children and children with primary snoring limited the generalizability of findings. In addition, because caregivers were not masked, some of the parent-reported outcomes may have been inflated. CONCLUSIONS AND RELEVANCE: The results of this narrative review suggest that CHAT provides a model for future OSA-related studies in children for design, conduct, and subsequent reuse of the study data set, and its findings have advanced our understanding of the pathophysiology and management of pediatric nonsevere OSA. Directions for future research include whether the findings from this landmark study are generalizable to younger children and children with primary snoring and severe OSA. Similar studies may help address practice variability associated with pediatric OSA and help identify children who are most likely to benefit from undergoing eAT.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Decuzzi J, Redline S, Isaiah A, et al. Secondary Analyses of the Childhood Adenotonsillectomy Trial: A Narrative Review. JAMA Otolaryngol Head Neck Surg. 2022. PMID: 35737366. doi:10.1001/jamaoto.2022.1330

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。